Loading
No insider purchase over the last 90 days. The latest, by Wilson Sam, was filed 09 Mar 2026.
Thomson Medical Group Limited is a listed company. Its insiders report their share dealings to SGX. From 20 October 2025 to 20 October 2026, the disclosure feed for Thomson Medical Group Limited logged 2 filings by 2 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 chief executives.
The last insider purchase was made public on 9 March 2026, 226 days ago.
For context, the typical company on the same exchange (median of 393 companies) published 6 filings over the same period, against 2 filings here. Since 2017, the database holds 13 purchases and 19 sales by insiders of the company.
Source: insider filings from SGX. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2026 · cache
25 of 52 declarations
Thomson Medical Group Limited is a healthcare company based in Singapore, specializing in medical services and care for mothers and children. It is listed on the Singapore Exchange, XSES.